The effects of lazaroid U-74389G in a rat sepsis model

Inflamm Res. 2011 Jan;60(1):29-35. doi: 10.1007/s00011-010-0231-3. Epub 2010 Jul 11.

Abstract

Objective and design: To examine the protective effects of a lazaroid, 21-aminosteroid U-74389G, in a rat septic shock model.

Materials or subjects: Male Sprague-Dawley rats (n = 60) aged 6-8 months.

Treatment: Groups were exposed to 500 cGy radiation followed by E. coli inoculation, and either placebo or lazaroid injection (10 mg/kg intraperitoneal) 5 days after irradiation.

Methods: Hemodynamic measurements, arterial blood gases, serum lactate, total antioxidative capacity, and cytokine levels were measured at specific time intervals.

Results: Treatment with the lazaroid U-74389G maintained cardiac output and mean aortic pressure. Lazaroid treatment also prevented the increase in serum lactate seen in placebo-treated rats. Cytokine serum levels in lazaroid-treated rats were not significantly different from those in placebo-treated rats at any time point.

Conclusions: Lazaroid treatment of E. coli-inoculated septic animals lessens the hemodynamic deterioration seen in sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Escherichia coli / immunology
  • Escherichia coli / pathogenicity
  • Hemodynamics / drug effects
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Placebos
  • Pregnatrienes / pharmacology
  • Pregnatrienes / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / drug therapy*
  • Sepsis / mortality
  • Sepsis / physiopathology
  • X-Rays

Substances

  • Immunosuppressive Agents
  • Placebos
  • Pregnatrienes
  • U 74389F